The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome

Konrad Lewandowski; Magdalena Kaniewska; Katarzyna Karłowicz; Mariusz Rosołowski; Grażyna Rydzewska

doi:10.5114/pg.2021.112681

Streszczenie

1/2022 vol. 17

Artykuł oryginalny

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome

Konrad Lewandowski ¹

,

Magdalena Kaniewska ¹

,

Katarzyna Karłowicz ¹

,

Mariusz Rosołowski ^{2, 3}

,

Grażyna Rydzewska ^{1, 4}

Clinical Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Unit, Central Clinical Hospital of the Ministry of the Inferior and Administration, Warsaw, Poland
Department of Internal Medicine and Hypertension, Medical University of Bialystok, Bialystok, Poland
Department of Hypertension, Gastroenterology and Internal Medicine, Medical University of Bialystok Clinical Hospital, Bialystok, Poland
Collegium Medicum, Jan Kochanowski University, Kielce, Poland

Gastroenterology Rev 2022; 17 (1): 28–34

DOI: https://doi.org/10.5114/pg.2021.112681

Data publikacji online: 2022/01/18

Pełna treść artykułu

AMA

Lewandowski K, Kaniewska M, Karłowicz K, Rosołowski M, Rydzewska G. The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome. Gastroenterology Review/Przegląd Gastroenterologiczny. 2022;17(1):28-34. doi:10.5114/pg.2021.112681.

APA

Lewandowski, K., Kaniewska, M., Karłowicz, K., Rosołowski, M., & Rydzewska, G. (2022). The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome. Gastroenterology Review/Przegląd Gastroenterologiczny, 17(1), 28-34. https://doi.org/10.5114/pg.2021.112681

Chicago

Lewandowski, Konrad, Magdalena Kaniewska, Katarzyna Karłowicz, Mariusz Rosołowski, and Grażyna Rydzewska. 2022. "The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome". Gastroenterology Review/Przegląd Gastroenterologiczny 17 (1): 28-34. doi:10.5114/pg.2021.112681.

Harvard

Lewandowski, K., Kaniewska, M., Karłowicz, K., Rosołowski, M., and Rydzewska, G. (2022). The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome. Gastroenterology Review/Przegląd Gastroenterologiczny, 17(1), pp.28-34. https://doi.org/10.5114/pg.2021.112681

MLA

Lewandowski, Konrad et al. "The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 17, no. 1, 2022, pp. 28-34. doi:10.5114/pg.2021.112681.

Vancouver

Lewandowski K, Kaniewska M, Karłowicz K, Rosołowski M, Rydzewska G. The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome. Gastroenterology Review/Przegląd Gastroenterologiczny. 2022;17(1):28-34. doi:10.5114/pg.2021.112681.

Streszczenie

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome

Udostępnij

Dostępne w

Indeksowane w

Zintergrowane z

Zasady redakcyjne